The findings from the global demethylation assay further support the notion that hypermethylation of MEG3-DMR CGIs could, at least in part, influence the region’s expression, as evidenced by the restored expression of these lncRNAs in tumor cell lines post-treatment. The gene discussed is MEG3; the disease is neoplasm.